Market evolution: Dialysis equipment (CN 90189030) — 2015–2025

Introduction

This report analyses the evolution of EU trade in renal dialysis equipment — classified under Combined Nomenclature code 90189030, covering "artificial kidneys, kidney machines and dialysers" — over the period 2015–2025. This is a strategically significant segment of the medical device industry, where chronic kidney disease prevalence drives sustained global demand and where the EU hosts several major manufacturers.

The period under review coincides with several structural shifts: the maturation of home-based and peritoneal dialysis models, the COVID-19 pandemic's strain on hospital-based care, post-pandemic supply chain reshoring, and growing healthcare investment in emerging economies. The data reveals a European Union that has consolidated its position as a dominant net exporter — with exports nearly doubling in value — while simultaneously reshaping its supplier base and facing both new opportunities and new sources of volatility.

1. A consolidation of the EU's net-exporter position

Over the 2015–2025 period, the EU significantly expanded its trade in renal dialysis equipment in both directions, but exports grew faster, widening the bloc's trade surplus.

1.1 Trade flows expanded substantially in value and volume

EU exports grew from €747 million in 2015 to €1,256 million in 2025 — a 68.2% increase. Over the same period, imports rose from €255 million to €476 million (+86.4%). In volume terms, the growth rates were closely aligned — exports up 57.9% and imports up 56.5% — suggesting that the divergence in value growth is primarily driven by price dynamics rather than pure tonnage.

1.2 The EU commands a steep price premium over imports

A defining structural feature of this market is the wide and persistent gap between EU export and import unit prices. EU exports averaged €34,790/t in 2015, rising to €37,053/t in 2025 (+6.5%). By contrast, imports were priced at only €11,296/t in 2015, reaching €13,449/t in 2025 (+19.1%).

This means that EU export prices are roughly 2.7 times the import price. This gap likely reflects the EU's specialisation in higher-value equipment (machines, controllers, and sophisticated dialysers) while importing more commoditised or lower-complexity components and finished goods from lower-cost origins. The faster price growth on the import side (+19.1% vs. +6.5%) may signal rising costs in supplier countries or a shift in the composition of imports towards higher-value goods.

1.3 The trade surplus widened, reflecting deeper export dependence

The EU's trade balance rose from €492 million to €780 million, peaking at €811 million in the period. The net import reliance indicator — which is negative when the EU is a net exporter — deepened from -51.5% to -94.9%, nearly doubling in magnitude. This confirms that the EU's role as a supplier of renal dialysis equipment to the world has intensified rather than eroded over the decade.

2. Geographic diversification and the rise of new supply hubs

A second major dynamic is the geographic reshaping of both the EU's supplier base and its export destinations, with significant shifts in partner rankings.

2.1 The import supply base has diversified towards Southern and Eastern Europe

The most striking change on the import side is the emergence of Türkiye and Serbia as the two largest non-EU suppliers. Türkiye's exports to the EU grew from €63 million to €144 million (+128.4%), while Serbia surged from €41 million to €113 million (+175.6%). Tunisia went from under €1 million to €51 million, representing a near-complete restructuring of its role. Meanwhile, Singapore and Japan — two mature Asian suppliers — saw their shares erode, with Singapore falling by 63.4% and Japan essentially flat.

This shift towards proximate and EU-candidate or neighbourhood countries is consistent with broader trends of nearshoring in medical device supply chains, the EU–Türkiye customs union framework, and Serbia's integration into EU industrial networks.

2.2 Export destinations have tilted strongly towards North America

On the export side, the most dramatic growth was in shipments to the United States, which more than doubled from €89 million to €205 million (+129.7%), making the US the EU's single largest export market by 2025. Mexico also surged (+189.2%), and South Korea grew by 46.5%. By contrast, Russia declined by 27.7% — likely reflecting sanctions and geopolitical disruption — and the United Kingdom fell slightly (-7.8%), possibly due to post-Brexit trade frictions.

The growing US share is consistent with rising demand for home dialysis and the US Inflation Reduction Act's incentives for medical device innovation, while the decline in Russian trade mirrors the post-2022 sanctions regime.

2.3 Within the EU, Germany dominates production and exports

Among EU member states, Germany is by far the dominant exporter, accounting for €806 million in 2025 (up 62.8%). Its RCA of 1.50 confirms a clear comparative advantage. Belgium emerged as a dramatic exporter (+513.9%), while France also surged from a low base (+594.6%). On the import side, Slovenia underwent a remarkable transformation, with imports rising from €0.7 million to €162 million — almost certainly reflecting the establishment of a major production or logistics hub on EU territory, supported by its exceptionally high RCA of 25.88.

The export concentration HHI of 725 indicates a moderately fragmented export base, while the import HHI of 1,780 — and rising — signals that import sourcing, though broad, is becoming somewhat more concentrated on a few key suppliers.

3. Production expansion, price dynamics, and supply volatility

A third set of dynamics concerns the industrial base underpinning this trade: EU production scaled up significantly, prices remained broadly stable on the export side, and some import channels exhibited notable volatility.

3.1 EU production more than doubled in value

EU production of renal dialysis equipment grew from €739 million to an estimated €1.5 billion (+103.0%) in value, and from 66 million items to 120 million items (+81.8%) in quantity over the period. Notably, production value growth (+103%) outpaced production volume growth (+82%), confirming a rising unit value of output — consistent with product upgrades and a shift towards higher-specification devices.

This industrial expansion also explains why the EU's export propensity — the share of production exported — rose from 51.9% to 77.2%. The EU is not only producing more; it is exporting a growing share of that output, indicating that domestic demand growth has been outpaced by international demand.

3.2 Export prices remained broadly stable, anchoring market positioning

EU export prices showed low overall volatility, ranging between €30,621/t and €37,564/t over the decade, with a modest overall increase of 6.5%. The fact that prices held relatively steady even as volumes surged suggests that EU manufacturers maintained their competitive positioning without engaging in aggressive price competition — consistent with a strategy focused on quality, reliability, and regulatory compliance in high-value markets.

Import prices, by contrast, rose faster (+19.1%) and showed a narrower range, suggesting more structural cost pressures from supplier countries or a shift in the product mix towards higher-value imports.

3.3 Specific import channels showed significant price volatility and shocks

Despite the relatively smooth aggregate picture, the volatility analysis reveals considerable variation at the partner level. Among import sources, Tunisia (CV = 0.98) and China (CV = 0.50) exhibited the highest price volatility, while Japan (CV = 0.09) and Türkiye (CV = 0.10) were notably stable.

The most prominent supply shock detected was a price spike in Chinese imports in 2023, with an abnormality score of 219.7 and a price shift of +99.2%. A Singapore price shock was detected the same year (abnormality 47.0, shift +41.2%), while a smaller Serbian export price shock occurred in 2018. These events may reflect supply chain disruptions, currency movements, or shifts in product mix, but they point to the importance of monitoring individual supplier price stability alongside aggregate trends.

Conclusion

Over 2015–2025, the EU consolidated and deepened its position as the world's leading net exporter of renal dialysis equipment. Trade volumes roughly doubled in both directions, but the EU's superior pricing power and productive capacity — with output growing 82–103% — ensured a widening trade surplus reaching €780 million. Export prices remained remarkably stable, supporting the EU's positioning in premium segments, while production shifted towards higher-value devices.

The geographic landscape has been substantially reshaped. On the supply side, Türkiye, Serbia, and Tunisia have displaced traditional Asian suppliers, aligning with nearshoring trends and EU neighbourhood policy. On the demand side, the United States has become the EU's primary export market, while Russian trade has contracted due to geopolitical factors. Within the EU, Germany anchors the industry, but Belgium, France, and notably Slovenia have emerged as increasingly significant players.

Risks remain concentrated in specific import channels, where individual partners have shown significant price volatility and occasional supply shocks. However, the broadening of the EU's supplier base — combined with its strong production base and growing export propensity — suggests a sector that is structurally resilient, even as it becomes more deeply integrated into global trade flows.